News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - IPO
ASLAN Announces Intention To Launch An Initial Public Offering On Taipei Exchange 4/26/2017
Shaanxi Kanghui Pharma Completes $52 Million Shanghai IPO 4/24/2017
Tocagen Announces Closing Of Initial Public Offering And Exercise Of The Underwriters' Option 4/20/2017
Galapagos (GLPG.BR) Locks In $338 Million In A U.S. Public Offering 4/18/2017
Biopharma IPOs Sluggish In Q1. Will That Continue? 4/14/2017
It's Official: Ovid CEO Just Filed for $86 Million IPO 4/13/2017
Cellectis (CLLS) To Explore Possible Initial Public Offering Of Calyxt 4/13/2017
Tocagen Announces Pricing Of Initial Public Offering 4/13/2017
ASLAN Plans $40 Million Taiwan IPO In May 4/13/2017
Investors Ready for Brain Cancer Biotech Tocagen's Upcoming IPO This Wednesday 4/11/2017
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC (AZN), Bristol-Myers Squibb (BMY) Drugs 4/11/2017
Candid Truths From A Biotech IPO 4/7/2017
Zymeworks Files Registration Statement For Proposed Initial Public Offering 4/3/2017
WuXi AppTec Plans China IPO 3/28/2017
Week In Review: BGI Plans $250 Million Shenzhen IPO 3/20/2017
Kangtai Biological Products Co. Ltd.'s Stock Price Rises 12-Fold Following Shenzhen IPO 3/17/2017
Georgia's Visioneering Technologies Successfully Snags $33.3 Million IPO 3/16/2017
BGI Re-Files To Raise $250 Million In Shenzhen IPO 3/16/2017
Myomo Launches Initial Public Offering Via Jobs Act Regulation A+ With Sights Set On Historic NYSE MKT Listing 3/15/2017
BeyondSpring Pharmaceuticals Prices Initial Public Offering And Concurrent Private Placement Of $54.31 Million 3/9/2017
Global Blood Therapeutics (GBT) Prices A $125.0 Million Upsized Common Stock Public Offering 2/22/2017
UK Investment Life Sci Firm Arix Bioscience Hits £100 Million IPO Goal 2/17/2017
Biotech IPOs Slow As Trump-Sown Uncertainty Rattles Nerves On Wall Street 2/15/2017
Myovant (MYOV) Moves From Launch To IPO To Phase 3 Trials In Just 6 Months 1/27/2017
Cambridge Biotech Jounce (JNCE) Bounces on the IPO Scene, Raises $102 Million 1/27/2017
ObsEva (OBSV) Release: Pharma Announces Pricing Of Initial Public Offering 1/26/2017
AnaptysBio (ANAB) Release: SoCal Biotech Goes Public, Raises $75 Million 1/26/2017
Here's a Biotech IPO You Don’t Want To Miss 1/9/2017
Week In Review: China's New Century Healthcare Plans Hong Kong IPO 1/3/2017
Cambridge-Based Jounce (JNCE) Files for $75 Million IPO 1/3/2017
CanniMed Completes Initial Public Offering 12/29/2016
Biotech Pros Say The Sector Is Poised For A Comeback In 2017 12/29/2016
Visterra, Inc. Gears Up For IPO 12/27/2016
Hebron Technology Co. (HEBT) Announces Pricing Of Initial Public Offering 12/27/2016
CanniMed Files Final Prospectus And Announces Pricing For Initial Public Offering 12/22/2016
TiGenix Raises $35.65 Million Gross Proceeds With NASDAQ IPO 12/15/2016
Armed With IPO Cash, CRISPR Biotechs Grow Gene-Editing Tech 12/14/2016
SenesTech Announces Pricing of Initial Public Offering 12/8/2016
TiGenix Announces Launch Of Proposed Initial Public Offering In The United States 12/6/2016
Manhattan Scientifics, Inc. Announces Agreement To Spin-Off And IPO Its Senior Scientific Unit 11/29/2016
Verona Pharma (VRP.L) Plans To Conduct Registered Initial Public Offering In The U.S. 11/23/2016
Week In Review: Week's China Life Science Deals Total $795 Million 11/22/2016
Asymchem Laboratories, Inc., A Tianjin CMO, Raises $125 Million In Shenzhen IPO 11/21/2016
BeyondSpring Pharmaceuticals, A US-China Pharma, Files For $100 Million IPO 11/17/2016
Asymchem Laboratories, Inc. Announces Its Initial Public Offering 11/17/2016
Samsung Biologics Raises $2 Billion In Korean IPO 11/14/2016
Week In Review: Investors Embrace Future Of Biologics Drugs In Samsung Biologics ' $2 Billion IPO 11/14/2016
Betta Pharmaceuticals Completes $106 Million IPO In Shenzhen 11/8/2016
Week In Review: Chi-Next Exchange Rejects BGI's $260 Million IPO Application 11/7/2016
BGI's Shenzhen IPO Rejected By China Regulators 11/4/2016
Meet the 31-Year Old Man Behind This Year’s Biggest Biotech IPO 11/1/2016
Week In Review: China Resources Pharmaceutical Stages $1.8 Billion Hong Kong IPO 10/31/2016
China Resources Pharmaceutical Starts Trading Following $1.8 Billion IPO 10/31/2016
Ra Pharma (RARX)'s $92 Million Debut is the Ninth Massachusetts Biotech IPO of 2016 10/27/2016
ConvaTec Conjures Up 1.5 Billion Pounds in London Listing 10/26/2016
CRISPR (CRSP)'s Surprisingly Low IPO… Why Are Investors Discouraged? 10/21/2016
CRISPR (CRSP) IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year 10/20/2016
Bloomberg: Samsung Biologics And Wuxi Biologics Plan IPOs For their Biologic CMOs 10/17/2016
Week In Review: China Resources Pharmaceutical To Price $2 Billion Hong Kong IPO This Week 10/17/2016
China Resources Pharma To Start Taking Orders For $2 Billion Hong Kong IPO 10/12/2016
4 Biotech IPOs that Have Performed the Worst This Year 10/12/2016
AzurRx BioPharma (AZRX) Announces Pricing Of Initial Public Offering 10/12/2016
Obalon Prices $75 Million IPO for Ingestible Weight Loss Balloon 10/7/2016
Fulgent Genetics Announces Potential Pricing For IPO 9/29/2016
Celon Pharma Had The Largest IPO On The Polish Capital Market In 2016 9/26/2016
Jacobson Pharma, A Hong Kong Generic Drugmaker, Stages $85 Million IPO 9/21/2016
China Resources Pharma OK'd To Raise $2 Billion In Hong Kong IPO 9/12/2016
Week In Review: China Resources Pharma To Raise $2 Billion In Hong Kong IPO 9/12/2016
Novan Files Paperwork for $60 Million IPO to Develop Skin Drugs 8/26/2016
Bay Area's Protagonist (PTGX) Raises $90 Million in Upsized IPO 8/11/2016
Samsung Biologics Seeks To Raise Up To $2.5 Billion From IPO 8/10/2016
Protagonist Therapeutics, a GI Biotech, Sets Terms for $70 Million IPO 8/1/2016
Week In Review: Crown Bioscience, A US-China CRO, Applies For Taiwan Listing 8/1/2016
Crown Bioscience Is One of Several Life Science Companies Planning Taiwan IPO 7/29/2016
Patheon (PTHN)'s Much-Anticipated IPO Prices at $21 a Share 7/21/2016
Advanced Enzyme IPO Kicks Off, Sees Subscription Of 89% On Day 1 7/20/2016
Audentes (BOLD) Makes Its IPO Debut Today 7/20/2016
PHARNEXT Announces The Successful Completion Of Its IPO Raising €31 Million On The Euronext Alternext Stock Exchange In Paris 7/15/2016
Australian Drug Discovery Company AdAlta Pty Ltd., Announces IPO To Accelerate New Therapies For Lung Fibrosis 7/8/2016
ASLAN Pharmaceuticals Pte Ltd Raises U.S.$23 Million In Pre-IPO Financing Round 7/5/2016
Cambridge-Based Syros Pharma Gets $50M in Market Debut 6/30/2016
Spring Rain Mobile Healthcare App Raises $183 Million, Plans China IPO 6/24/2016
With Selecta (SELB)'s $70 Million IPO, Mass Biotechs Raised a Total of $376 Million This Year 6/24/2016
Week In Review: Gan & Lee To Raise $266 Million In Shanghai IPO 6/20/2016
Gan & Lee Plans $226 Million China IPO 6/17/2016
Sensus Healthcare (SRTSU) Prices $11 Million IPO 6/3/2016
Patrick Soon-Shiong's NantHealth (NH) Explodes onto Market in IPO Debut 6/3/2016
Clearside Biomedical (CLSD) Announces Pricing Of Initial Public Offering 6/2/2016
Merus Announces Pricing Of Initial Public Offering 5/19/2016
Oncobiologics Announces Pricing Of Its Initial Public Offering Of Units 5/13/2016
PAVmed (PAVMU) IPO Brings in $5.3 Million 4/29/2016
Proteostasis (PTI) Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO 2/11/2016
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016
Bay Area's First New Public Company of 2016 is OncoCyte 1/4/2016
GenScript Stages $68 Million IPO In Hong Kong 12/31/2015
The Children's Hospital of Philadelphia Participates In Spark Therapeutics (ONCE) Public Offering 12/16/2015
Accelerate Diagnostics (AXDX) Announces Pricing Of Public Offering Of Common Stock 12/10/2015
Voyager Therapeutics (VYGR) Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares 11/17/2015
Wave Life Sciences (WVE) Raises $102 Million in IPO 11/11/2015
Voyager Therapeutics (VYGR) Reels in $70 Million in IPO 11/11/2015
MyoKardia Announces Closing Of Initial Public Offering 11/4/2015
Dimension Therapeutics Prices IPO at Lower End of the Range But Still Manages to Reel in $72 Million 10/22/2015
Strongbridge Biopharma Announces Pricing Of Its Initial U.S. Public Offering 10/16/2015
Cerecor Inc. Announces Pricing Of Initial Public Offering 10/15/2015
Aclaris (ACRS) Announces Pricing Of IPO 10/7/2015
NovoCure Prices $165 Million IPO 10/2/2015
Aclaris Therapeutics Sets Terms for $75 Million IPO 9/28/2015
Bioceres Files for an $81 Million U.S. IPO 9/28/2015
Mirna Sets Terms For $65 Million IPO 9/18/2015
Should You Invest in Nabriva IPO? 9/18/2015
Penumbra's $120M IPO Soars Early 9/18/2015
REGENXBIO Takes Center Stage With $139M IPO 9/17/2015
SynCardia Sets Terms For $28 Million IPO 9/16/2015
Gene Therapy Biotech REGENXBIO Increases Proposed IPO Price To $22 9/16/2015
Swedish Cancer Biotech Oasmia Narrows Range For IPO 9/16/2015
Cambridge’s Dimension Therapeutics Preps for $115 Million IPO 9/15/2015
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of $80 Million Of Common Stock 9/15/2015
Intrexon Announces Closing Of $230 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/26/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
Inotek Pharmaceuticals Corporation (ITEK) Announces Pricing Of $68.9 Million Public Offering 8/13/2015
Zynerba Announces Pricing Of Its Initial Public Offering 8/5/2015
Adherium $35 Million ASX IPO To Expand Sales Of Digital Health Technology To Improve Medication Adherence 8/5/2015
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 8/4/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever 8/4/2015
vTv Therapeutics Announces Pricing Of Initial Public Offering 7/30/2015
Neos Therapeutics Announces Pricing Of Initial Public Offering 7/23/2015
Eye Sees More Gene Therapy: GenSight Biologics Files For A $100 Million IPO 7/7/2015
Bay Area's Natera Guns for a $175 Million IPO 7/2/2015
ConforMIS Prices $135 Million IPO 7/1/2015
Seres Therapeutics Raises $133M for State's Second-Largest Bio IPO, As Rival OpenBiome Grows 6/26/2015
Catabasis Pharmaceuticals, Inc. Shares Surge In Nasdaq Debut; Upsizes to Grab $60M in IPO 6/25/2015
Lantheus Holdings Prices IPO At $6, Below The Range 6/25/2015
GC Aesthetics Files For A $75 Million IPO 6/25/2015
Ritter Takes a Run at Public Markers With $20M IPO 6/24/2015
Benitec (BLT.AX) Files $70 Million IPO As Gene Therapy Booms 6/24/2015
Massachusetts Debuts Three Biotech IPOs for $235M As Market Roars 6/24/2015
Nivalis Therapeutics IPO Nets $88M 6/23/2015
Billionaire's Conkwest Aims for $172.5 Million IPO, While Neos Therapeutics Asks for $69 Million 6/22/2015
Biotech Neos Therapeutics Files for a $69 Million IPO 6/22/2015
Ousted Sanofi (SAN.PA) CEO's PureTech Nabs $171 Million in London IPO 6/22/2015
Celyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO 6/19/2015
BioCardia Seeks $58 Million IPO 6/17/2015
vTv Therapeutics Files Registration Statement For Proposed Initial Public Offering 6/16/2015
Axovant (AXON) Takes Center Stage With Biggest Biotech IPO Ever, Baby-Faced CEO 6/15/2015
Axovant Prices IPO At $15, The Upper End Of The Range 6/11/2015
3SBio Inc. (SSRX) Sets Target Of $712 Million For Hong Kong IPO 5/28/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Jaguar Animal Health Announces Pricing of IPO 5/13/2015
BiondVax Pharmaceuticals Announces Pricing Of U.S. IPO Of 1,910,000 Adss And Warrants To Purchase 1,910,000 Adss 5/12/2015
Adaptimmune Announces Closing Of IPO 5/11/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
Collegium Announces Pricing Of Its IPO 5/7/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Adaptimmune Announces Pricing Of IPO 5/6/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
As Market Froths, Blueprint Medicines (BPMC) Debuts $147 Million IPO for Massachusetts' Biggest Recent IPO 5/1/2015
Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong 4/22/2015
Aduro Biotech (ADRO) Launches $119 Million IPO with Hot Cancer Tech 4/16/2015
KemPharm Sets Terms for $52 Million IPO 4/9/2015
IPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the Sidelines 4/6/2015
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/2/2015
Botox Biotech Anterios Files For A $58 Million IPO 4/1/2015
After Exiting RTP, CoLucid Pharma Files with SEC for $86M IPO 4/1/2015
Cancer Gene Therapy Biotech MultiVir Files for a $70M IPO 3/30/2015
Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues 3/27/2015
Applied DNA Sciences, Inc. (APDN) Prices $11.46 Million Public Offering 3/27/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
Zhejiang ChiMin Pharma Stages $47 Million IPO In Shanghai 3/23/2015
Cancer Biotech Cellectis (ALCLS) Sets Terms For $129 Million IPO 3/20/2015
SteadyMed Launches IPO 3/10/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
VolitionRX Announces Exercise Of Over-Allotment Option In Previously Announced Public Offering 2/17/2015
Nexvet Biopharma plc Announces Pricing Of IPO 2/5/2015
BBI Life Sciences Stages $37 Million IPO in Hong Kong 2/5/2015
Flex Pharma (FLKS) Announces Closing Of Initial Public Offering 2/4/2015
TRACON Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering 1/30/2015
Unilife Corporation (UNIS) Announces Public Offering Of Common Stock 1/30/2015
Spark Therapeutics (ONCE) Announces Pricing of Its Initial Public Offering 1/30/2015
Cancer Biotech Kolltan Pharmaceuticals Inc. Withdraws $86 Million IPO 1/29/2015
Massachusetts's Inotek Pharmaceuticals Corporation Sets Terms for $65 Million IPO 1/23/2015
Silicon Valley Biotech Carbylan Therapeutics Files for $86 Million 1/2/2015
San Diego Biotech TRACON Pharmaceuticals, Inc. (TCON) Files for $58 Million IPO 12/30/2014
Growth Hormone Biotech Ascendis Pharma A/S Files For A $86 Million IPO 12/19/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Universal Flu Vaccine Co BiondVax Pharmaceuticals Mulls NY IPO 11/24/2014
Neothetics Prices IPO 11/20/2014
Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO 11/19/2014
Juno Therapeutics (JUNO) Files For IPO 11/17/2014
NeuroDerm Ltd. (NDRM) IPO Disappoints 11/14/2014
INC Research, Inc. (INCR) Announces Closing Of IPO 11/14/2014
CRO PRA Health Sciences Sets Terms For $400 Million IPO 11/5/2014
TPG-Backed Biotech Virobay Inc. Withdraws $50 Million IPO 11/3/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Xenon Pharmaceuticals Inc. Postpones IPO 10/20/2014
Neothetics Files To Raise $63 Million To Fight Fat With An Asthma Drug 10/20/2014
Insulin Biotech Dance Biopharma Withdraws $75 Million IPO 10/17/2014
Bone Biotech PolyPid Ltd. Files For A $24 Million IPO 10/16/2014